Perceptive Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-978,277
| Closed | -$23.1M | – | 142 |
|
|
2021
Q2 | $23.1M | Hold |
978,277
| – | – | 0.3% | 78 |
|
|
2021
Q1 | $23.2M | Sell |
978,277
-1,079,791
| -52% | -$25.6M | 0.29% | 72 |
|
|
2020
Q4 | $41.2M | Hold |
2,058,068
| – | – | 0.44% | 53 |
|
|
2020
Q3 | $42.8M | Hold |
2,058,068
| – | – | 0.63% | 42 |
|
|
2020
Q2 | $36M | Buy |
2,058,068
+506,346
| +33% | +$8.86M | 0.58% | 41 |
|
|
2020
Q1 | $25.3M | Buy |
1,551,722
+1,130,450
| +268% | +$18.5M | 0.66% | 38 |
|
|
2019
Q4 | $8.67M | Buy |
+421,272
| New | +$8.67M | 0.17% | 69 |
|
|
2019
Q1 | – | Sell |
-445,000
| Closed | -$7.37M | – | 104 |
|
|
2018
Q4 | $7.37M | Buy |
+445,000
| New | +$7.37M | 0.28% | 57 |
|
|
2018
Q3 | – | Sell |
-24,213
| Closed | -$577K | – | 120 |
|
|
2018
Q2 | $577K | Buy |
+24,213
| New | +$577K | 0.02% | 107 |
|
|
2017
Q1 | – | Sell |
-196,728
| Closed | -$3.06M | – | 168 |
|
|
2016
Q4 | $3.06M | Buy |
+196,728
| New | +$3.06M | 0.22% | 70 |
|